Graham J Cox

Title: Graham J Cox: Innovator in Bovine Coronavirus Research

Introduction

Graham J Cox is a notable inventor based in Saskatoon, Canada. He has made significant contributions to the field of veterinary infectious diseases, particularly through his innovative research on bovine coronaviruses. With a total of 3 patents, his work has implications for vaccine development and treatment methods in veterinary medicine.

Latest Patents

Cox's latest patents include groundbreaking advancements in the use of fusion proteins. His patents focus on the development of recombinant bovine coronavirus E2 and E3 polypeptides and vaccines. Additionally, he has worked on nucleic acid sequences encoding the Bovine Coronavirus E2 (or BCV S) and E3 (or BCV HE) structural glycoproteins. These innovations provide methods for producing these proteins, including recombinant expression in mammalian or insect cells. The E2 and E3 proteins, or their antigenic fragments, are essential components for Bovine Coronavirus vaccines and treatment methods.

Career Highlights

Throughout his career, Graham J Cox has been associated with prominent organizations such as the Veterinary Infectious Disease Organization and Biostar, Inc. His work has been instrumental in advancing the understanding and treatment of infectious diseases in livestock.

Collaborations

Cox has collaborated with esteemed colleagues, including Michael D Parker and Lorne A Babiuk, further enhancing the impact of his research in the field.

Conclusion

Graham J Cox's contributions to veterinary medicine through his patents and research are invaluable. His work continues to influence the development of effective vaccines and treatments for bovine coronaviruses.